Paxman AB (publ)

Paxman AB (publ) has a market price of 11.56 SEK and a market capitalization of 269,040,688.96 SEK, indicating a moderate valuation in the healthcare equipment and supplies industry. The company's price-to-earnings ratio of 20.52 and price-to-book ratio of 1.98 suggest that investors are paying a premium for its earnings and book value. The enterprise value to EBITDA ratio of 38.65 and enterprise value to revenue ratio of 4.88 indicate that the company is valued at a high multiple of its earnings and revenue. In terms of profitability, Paxman AB (publ) has a return on equity of 9.63% and a return on assets of 7.13%, which are metrics that reflect the company's ability to generate profits from its equity and assets. The company's operating income of 7,405,000 SEK and net income of 13,108,000 SEK demonstrate its capacity to generate profits from its operations. However, these figures should be compared to the industry median to determine if they are above or below average. Paxman AB (publ) has a revenue of 58,620,000 SEK, and there is no specific information provided about its segments or geographic exposure. The company's revenue concentration is not detailed, but it is important to consider the potential risks associated with a lack of diversification in its revenue streams. The company's growth trajectory is reflected in its revenue and earnings estimates. The mean revenue estimate is 421,500,000 SEK, while the last actual revenue was 313,346,000 SEK, indicating a potential increase in revenue. The mean EPS estimate is 1.91 SEK, compared to the last actual EPS of -0.72 SEK, suggesting a significant improvement in earnings. These estimates should be monitored to assess the company's future performance. Paxman AB (publ) faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The company's capital structure includes total liabilities of 47,800,000 SEK and total equity of 136,050,000 SEK, with a debt-to-equity ratio of 0.13. The company's liquidity is further reflected in its current ratio of 2.35, which suggests that it has sufficient current assets to cover its current liabilities. However, the company has a negative net cash position after subtracting total debt, which could impact its liquidity. Recent events and filings for Paxman AB (publ) are not detailed in the provided data. Analysts have provided price targets ranging from 93.00 SEK to 103.00 SEK, with a mean of 98.00 SEK, indicating a positive outlook on the company's stock. The company's performance and strategic initiatives should be closely monitored to understand the factors driving these price targets.